Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease

by | Dec 6, 2024 | Scientific presentation

You are currently viewing a placeholder content from YouTube. To access the actual content, click the button below. Please note that doing so will share data with third-party providers.

More Information

Speaker | Nadia Ashrafi, Ph.D.
Affiliation | Metabolomics Research Group | Corewell Health Research Institute | Corewell Health East William Beaumont University Hospital | Research Scientist


Metabolomic profiling of Cohort Consortium identifies prodromal biomarkers for Parkinson’s disease

Part of the
Corewell Health Metabolomics Symposium

Comprehensive metabolomic profiling of the LRRK2 Cohort Consortium (LCC) identifies prodromal biomarkers for Parkinson’s Disease


Related articles

Upcoming events

Metabolomics in Life Science

Date Jan 27 - 28, 2026Time All Day EventVenue Umeå University, Sweden

Metabolomics in Life Science 2026 in Umeå, Sweden, brings together researchers to present and discuss the latest advances in NMR- and MS-based metabolomics. The event features international keynote speakers, scientific sessions across life science disciplines, and an i...

More Info